insights_auto
Why is EDIT down 13,82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,87 US$
arrow_downward
-13,82%(-0,30) 1D
1,90 US$
arrow_upward
+1,60% (+0,030)bedtimeAfter hours
Closed: 16 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
2,11 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
2,11 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
Investing.com
·
21 წუთის წინ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.41%
The Motley Fool
·
1 საათის წინ
Here's How the S&P 500 Has Moved the Day After Each of Nvidia's Last 12 Reports
24/7 Wall St.
·
45 წუთის წინ
S&P 500 Closes Down 2% as Nasdaq Leads Broad Market Lower
ChartMill
·
1 საათის წინ
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc